BioElementis
BioElementis, licence 80095692: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- BioElementis
- NPN or DIN-HM
- 80095692
- Status
- Active licence
- Licence date
- 20 November 2019
- Revision date
- Not provided
- Form
- Liquide
- Route of administration
- Inhalation
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Cymbopogon flexuosus Source : Sommité | 100.0 % | Not calculated |
Non-medicinal ingredients
Not provided.
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 3.0 Goutte(s) ; maximum: 12.0 Goutte(s) | minimum: 1.0 Tous les jours ; maximum: 3.0 Tous les jours |
Uses authorised in Canada
Used in aromatherapy as a nervine/calmative. Used in aromatherapy to help relieve headache. Used in aromatherapy as a carminative/antispasmodic for symptomatic relief of digestive discomfort.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Keep out of reach of children. If accidental ingestion occurs, seek urgent medical attention or contact a Poison Control Center. If symptoms persist or worsen, consult a health care practitioner. If you have epilepsy or asthma, consult a health care practitioner prior to use.
- Effets indésirables connus
If you experience nausea, dizziness, headache or allergic reaction, discontinue use.
- Contre-indications
If you are pregnant or breastfeeding, do not use this product.
Source
Official Health Canada record, licence 80095692
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.